Sublingual oxytocin to prevent heavy bleeding after childbirth
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests a new under-the-tongue tablet (sublingual oxytocin) to prevent heavy bleeding after childbirth. It aims to see if it works safely in healthy women having a vaginal delivery at full term.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old.
- You are between 37 and 42 weeks pregnant with one baby.
- You are planning a vaginal delivery (not a C-section).
- You are generally healthy with no conditions that increase bleeding risk, like placenta problems or severe anemia.
- You have no mouth sores or dental issues that could affect the sublingual tablet.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medicines—carbetocin and oxytocin—given during a planned cesarean to help prevent heavy bleeding after delivery. It is for women who have certain risk factors for uterine atony (when the uterus does not tighten up after birth).
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
This study compares two ways to prevent heavy bleeding after a C-section. One uses a combination of three medicines, and the other uses a single medicine. The goal is to find which is safer and more effective at reducing blood loss.
This trial tests whether giving a drug called tranexamic acid before a planned C-section can reduce the risk of severe bleeding after birth. It is for women who are otherwise healthy and expecting a single baby.
This study tests whether using two medicines at the same time after delivery works better than using one medicine to prevent early heavy bleeding. It may help reduce the chance of postpartum hemorrhage soon after birth.
This trial tests two medicines given during a planned C-section to see which is better at preventing heavy bleeding. It may help make delivery safer for healthy women having a scheduled cesarean.
Hear when a new Post Partum Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.